Of note, we found that CDK4/6 inhibitor selectively suppressed cell viability of phospho-Rb-upregulated, recurrent cells, further supporting the critical role of cell cycle deregulation in progression in IDH2-mutant astrocytoma. The gene discussed is RB1; the disease is astrocytoma (excluding glioblastoma).